<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> is the major risk factor for intracerebral haemorrhage (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e>) and <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> (LI) and both types of <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">cerebral lesions</z:e> originate from pathology of the same deep perforating small arteries </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to evaluate the relationship between vascular risk factors including common carotid artery intima-media thickness (CCA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) with LI versus <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We prospectively collected data from 159 first ever <z:hpo ids='HP_0001297'>stroke</z:hpo> patients (67 cases with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> and 92 cases with LI) with documented history of <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> subjects underwent B-mode ultrasonographic measurements of the CCA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Logistic regression modelling was used to determine the factors (established vascular risk factors, severity and duration of <z:hpo ids='HP_0000822'>hypertension</z:hpo>, concomitant medications and CCA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) that may significantly differentiate LI from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Patients with LI had significantly (p=0.002) larger CCA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> values (0.926 mm, 95% CI: 0.881-0.971) than subjects with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> (0.815 mm, 95% CI: 0.762-0.868) even after adjusting for baseline characteristics and cardiovascular medications </plain></SENT>
<SENT sid="6" pm="."><plain>The multivariate logistic regression procedure selected CCA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and <z:e sem="disease" ids="C0020443" disease_type="Disease or Syndrome" abbrv="">hypercholesterolaemia</z:e> as the only independent factors able to discriminate between LI and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The risk for LI versus <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> increased continuously with increasing CCA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>For each increment of 0.1 mm in CCA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> the probability of suffering from LI versus <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> increased by 36.6% (95 % CI: 13%-65.2%, p=0.001) even after adjustment for <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Increased CCA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> values are a factor favouring LI over <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> in hypertensive patients </plain></SENT>
<SENT sid="10" pm="."><plain>The measurement of CCA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> may be a useful non-invasive diagnostic tool for the risk assessment of LI with respect to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> in such patients </plain></SENT>
</text></document>